Search ( 3960 results )
- article
(Updated on )
France Mobilizes in the Fight Against Viral Hepatitis [Editorial]
- article
(Updated on )
Prevalence of chronic hepatitis C and B and history of screening in the general population in 2016: a contribution to a new screening strategy, Santé publique France-BaroTest Barometer
The hepatitis C screening strategy is currently being reviewed by the French National Authority for Health (HAS). One of the options under consideration would involve combined screening...
- article
(Updated on )
Acceptability and Feasibility of Home-Based Self-Testing for HIV, HBV, and HCV Infections in the General Population in France in 2016: The BaroTest Study
Despite widespread screening for HIV and hepatitis B and C in France, many people remain undiagnosed. Santé publique France conducted a pilot study on screening for HBV, HCV, and HIV...
- article
(Updated on )
Surveillance of Acute Hepatitis B Through Mandatory Reporting, France, 2003–2018
Objectives - To analyze data from the surveillance of acute hepatitis B through mandatory reporting (MR) between 2003 and 2018. Method - Any case of acute hepatitis B, defined as the...
- article
(Updated on )
Direct-acting antivirals for the treatment of chronic hepatitis C: A review of four years of coverage by the National Health Insurance (January 2014–December 2017)
Introduction - Since late 2013, direct-acting antivirals (DAAs) have revolutionized the treatment of hepatitis C. Access to these drugs has gradually been expanded to all chronic...
- article
(Updated on )
Estimates of the number of acute hepatitis B diagnoses and the completeness of mandatory reporting in France in 2016: the 2016 LaboHEP survey
Objectives - To estimate the number of acute hepatitis B diagnoses and the completeness of mandatory reporting of acute hepatitis B (MR) in France in 2016. Compare the 2016 estimates...
- magazines/journals
(Updated on )
Weekly Epidemiological Bulletin, September 24, 2019, No. 24-25 National Day for the Fight Against Viral Hepatitis, 2019
- article
(Updated on )
Interventions to increase vaccination coverage for the human papillomavirus vaccine
Introduction - Identifying and implementing interventions that have been shown to be effective in increasing vaccination coverage (VC) for the human papillomavirus (HPV) vaccine are...
- article
(Updated on )
Cost-effectiveness analysis of human papillomavirus vaccination as part of cervical cancer screening in France
Introduction - The National Cancer Institute (INCa) sought to quantify the additional health benefits (precancerous lesions, cervical cancers, and deaths from cervical cancer prevented)...
- article
(Updated on )
Eradicating cervical cancer: a public health priority
